Portfolio company
POTENTIAL SCIENCES
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Potential Sciences develops GPU-native quantum chemistry simulation software for molecular modelling, serving customers in the pharmaceutical and biotechnology sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kvantify
This company develops quantum and classical computing software for molecular discovery and chemical simulations for life sciences and industrial businesses.
Algorithmiq
The company develops quantum computing algorithms and software for life sciences and pharmaceutical organisations to accelerate drug discovery and molecular modelling.
QMatter
QMatter develops quantum compression software for pharmaceutical and biotechnology companies to perform molecular simulations on classical and quantum hardware.
HQS Quantum Simulations
This company develops quantum simulation software for material scientists and chemical industry researchers to predict molecular properties and analyze complex spectroscopy data.
HTuO Biosciences
This company develops AtomForge, a physics-based molecular simulation platform providing drug discovery and lead optimisation services to pharmaceutical and biotechnology partners.
Nextmol
This company develops a computational chemistry software platform to accelerate the design and virtual testing of specialty chemicals for the manufacturing and R&D industries.
Freecurve
This company develops molecular simulation software for researchers in drug discovery and materials science to predict the physical behaviour of complex systems.
Qulab
This company develops artificial intelligence and quantum computing software to automate small molecule drug design for the pharmaceutical and chemical industries.
